Etidocaine Hydrochloride

CHEMBL1200597 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
312.9 g/mol
LogP
Phase
4

The hydrochloride salt form of etidocaine, this long-acting local anesthetic blocks pain signal transmission by preventing sodium from entering nerve cells. The salt form is used in injectable formulations for regional anesthesia.

Peso Molecular

312,9000 g/mol

TPSA

32,30 Ų

Mecanismo de Ação

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C.Cl

InChI

InChI=1S/C17H28N2O.ClH/c1-6-12-19(8-3)15(7-2)17(20)18-16-13(4)10-9-11-14(16)5;/h9-11,15H,6-8,12H2,1-5H3,(H,18,20);1H

Molecular Formula

C17H29ClN2O

HBD / HBA

2 / 2

Ligações Rotacionáveis

7

Átomos Pesados

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

The hydrochloride salt form of etidocaine, this long-acting local anesthetic blocks pain signal transmission by preventing sodium from entering nerve cells. The salt form is used in injectable formulations for regional anesthesia.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Etidocaine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200597. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9796823. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.